All Products

SLU-PP-332 500 mcg

Novel Metabolic Activator & Exercise Mimetic Compound

Lab Tested

Substance: SLU-PP-332
Strength: 500 mcg/tablet
Form: Oral tablets
Packaging: 100 tablets
Manufacturer: Dragon Pharma, Europe

Authentic Dragon Pharma Product

Free Shipping on Orders $800+

Discreet Packaging Guaranteed

$75.00

Warehouse :

International

U.S. Domestic

Dragon Pharma SLU-PP-332

Dragon Pharma SLU-PP-332 500 mcg represents the cutting edge of metabolic pharmacology, offering a groundbreaking "exercise mimetic" approach to body composition and performance. This innovative compound, developed from university research, is designed to activate the same biological pathways that are naturally stimulated by prolonged aerobic exercise. Unlike traditional stimulant-based fat burners, SLU-PP-332 works by targeting estrogen-related receptors (ERRα, ERRβ, and ERRγ), which are master regulators of energy metabolism in muscles, the heart, and the brain. By pharmacologically "telling" your skeletal muscle to behave as if it's endurance-trained, this compound can shift your entire body's metabolism towards increased fat burning and energy expenditure, even at rest.

Produced under strict cGMP standards in Dragon Pharma's European facilities, each 500 mcg tablet delivers a precise dose of this potent research compound. Pre-clinical studies published in peer-reviewed journals have demonstrated remarkable effects: treated subjects exhibited significantly increased whole-body fatty acid oxidation, reduced fat mass accumulation, and dramatically improved exercise endurance—in some cases by up to 70%. For the athlete or bodybuilder, this translates to a powerful tool for cutting phases. It promotes efficient fat loss by converting the body into a fat-burning furnace, while its muscle-preserving and endurance-boosting properties help you maintain training intensity and lean mass in a calorie deficit.

It is crucial to understand that SLU-PP-332 is a potent research chemical with a novel mechanism. While early data shows a promising safety profile with no severe side effects reported in animal models, and it is not hepatotoxic or linked to water retention or blood pressure issues, its long-term effects in humans are not yet fully characterized. Therefore, it is intended for informed research use by experienced individuals. Its non-stimulant, non-suppressive nature makes it a compelling alternative for those seeking results beyond conventional fat-loss agents.

Key Benefits:

Exercise-Mimetic Fat Loss: Activates ERR pathways to increase resting energy expenditure and shift fuel preference to fatty acids, promoting fat oxidation similar to the effects of cardio.
Significant Endurance Enhancement: Boosts mitochondrial function and oxidative capacity in muscle, potentially leading to substantial increases in stamina and workout capacity.
Muscle Preservation & Metabolic Health: Aids in maintaining lean tissue during cutting and may improve overall metabolic parameters, including insulin sensitivity.
Non-Stimulant Energy Boost: Provides increased energy and alertness through enhanced metabolic efficiency without the jitters, anxiety, or crash associated with catecholamine-based stimulants.
Favorable Safety Profile: Early research indicates no liver toxicity, water retention, or blood pressure issues, and it does not require Post Cycle Therapy (PCT).

Each sachet contains 100 tablets of 500mcg SLU-PP-332, manufactured under strict quality control standards in Dragon Pharma's certified facilities.

Product Specifications

Product Name	SLU-PP-332 500 mcg
Manufacturer	Dragon Pharma
Substance	SLU-PP-332
Packaging	100 tablets in sealed sachet
Lab Test Result	534.91 mcg (Oct 2025) - Exceeds label claim
Half-Life	Approximately 6 - 8 hours
Recommended Cycle	4 - 8 weeks
Form	Oral tablet
Aromatization	No
Dosage (Research)	500 - 1000 mcg per day (split into 2 doses)

Usage Guidelines

Important Note: SLU-PP-332 is an experimental research compound. The following guidelines are based on current non-clinical data and anecdotal reports. Start with the lowest dose to assess individual tolerance.

Beginner Research Cycle (4-6 weeks): Start with 500 mcg (1 tablet) per day. Due to its ~6-8 hour half-life, split this into two 250 mcg doses (half a tablet), taken in the morning and early afternoon. This protocol is excellent for assessing tolerance and initiating metabolic adaptation. It can be used as a standalone agent or stacked with foundational health supplements like NAD+ for cellular energy support.
Intermediate Cycle (6-8 weeks): After 1-2 weeks at 500 mcg, if well-tolerated, the dose can be increased to 750-1000 mcg per day. This is typically split as 250-500 mcg in the morning and another 250-500 mcg approximately 8 hours later. This range is used to pursue more pronounced endurance and recomposition effects. It stacks synergistically with peptides that support metabolic health, such as Tesamorelin.
Advanced Protocol (8 weeks max): 1000 mcg per day, strictly split into two 500 mcg doses. Reserved for experienced researchers. At this level, the focus is on maximizing the "exercise mimetic" effect. It can be integrated into a comprehensive cutting stack that includes muscle-preserving agents like LGD-4033 or a clean anabolic base such as Primobolan 100 to optimize the muscle-to-fat loss ratio.

Post Cycle Therapy (PCT):

SLU-PP-332 does NOT require a traditional PCT. It does not suppress the hypothalamic-pituitary-testicular axis (HPTA) or natural testosterone production. Its mechanism is purely metabolic, targeting ERR receptors rather than the endocrine system. Therefore, you can conclude your cycle without the need for SERMs like Clomid or Nolvadex. A gradual taper is not necessary but ceasing use is sufficient.

Support & Considerations:

While not hepatotoxic, supporting overall metabolic health is prudent. Ensure adequate hydration and a diet rich in micronutrients to support increased metabolic turnover. Some anecdotal reports mention transient fatigue, so listen to your body and ensure sufficient rest. For cardiovascular health in any cutting phase, consider support supplements like Omega-3s or CoQ10. As with any compound that alters metabolism, maintaining a balanced diet with sufficient protein is crucial to leverage its muscle-preserving potential.

Third-Party Lab Tested

Dragon Pharma SLU-PP-332 Lab Test Report October 16 2025

2025-10-16

View Result

534.91 mcg

Note: The independent third-party lab test dated October 16, 2025, confirms a potency of 534.91 mcg per tablet, exceeding the labeled 500 mcg claim. This demonstrates Dragon Pharma's commitment to consistent overdosing, ensuring you receive a product of verified and superior potency.

Storage Instructions

To preserve the integrity of this advanced compound, proper storage is essential.

Environment: Store in a cool, dry, and dark place. Avoid exposure to direct sunlight, excessive heat, and humidity.
Temperature: Maintain a stable temperature between 15°C and 25°C (59°F and 77°F). Do not freeze.
Container: Keep tablets in their original, sealed Dragon Pharma foil sachet. This packaging is designed to protect against light, moisture, and air.
Safety: Keep out of reach of children and pets. Store in a secure location away from general household medications.
Shelf Life: When stored under the recommended conditions, the product maintains optimal stability for up to 2 years from the manufacturing date. Do not use if the packaging is damaged.

What is the SLU-PP-332 peptide used for?

SLU-PP-332 is an experimental metabolic compound known as an 'exercise mimetic.' It is studied for its potential to provide benefits similar to endurance training, such as enhancing fat loss by increasing energy expenditure and fatty acid oxidation, boosting exercise endurance, and improving metabolic health. It works by activating estrogen-related receptors (ERRs) in energy-demanding tissues like muscle, effectively reprogramming metabolism without requiring increased physical activity.

What are the side effects of SLU-PP-332?

Current data from pre-clinical research indicates minimal severe side effects. However, due to its potent metabolic effects, some users may experience transient fatigue. It is not hepatotoxic, does not cause water retention or acne, and is unlikely to raise blood pressure. As an experimental research compound, its long-term safety profile in humans is not yet established. Responsible, low-dose use is recommended to assess individual tolerance.

How do you take SLU-PP-332 pills?

Dragon Pharma's SLU-PP-332 comes in convenient 500 mcg oral tablets. Based on current experimental protocols, a common daily dosage ranges from 500 mcg to 1000 mcg. Due to its active half-life of approximately 6–8 hours, the total daily dose is typically split into two administrations (e.g., morning and afternoon). It's crucial to start at the lower end of this range (500 mcg/day) to assess individual tolerance before considering any increase. A typical research cycle lasts 4 to 8 weeks.

Does SLU-PP-332 require Post Cycle Therapy (PCT)?

No, Post Cycle Therapy (PCT) is not required with SLU-PP-332. Unlike anabolic steroids or certain SARMs, SLU-PP-332 does not suppress the body's natural testosterone production or affect the hypothalamic-pituitary-gonadal (HPG) axis. Its mechanism targets metabolic pathways (ERR receptors) related to energy expenditure and fat oxidation, not the endocrine system. Therefore, you can conclude a cycle without the need for SERMs like Clomid or Nolvadex.

How does SLU-PP-332 compare to other fat loss compounds?

SLU-PP-332 represents a novel, non-stimulant approach. Unlike beta-2 agonists like Clenbuterol, which are stimulants that raise heart rate, or appetite suppressants like Sibutramine, SLU-PP-332 works by mimicking the cellular effects of aerobic exercise. It shifts the body's metabolism to use fat as its primary fuel source, potentially increasing endurance and preserving muscle during a calorie deficit. This makes it a unique tool for body recomposition with a different side effect profile.

No customer reviews yet.